IBD: Crohn's Disease
Transition Pathway Brochure for IBD Patients
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
Related Articles
Written by KR. A woman’s life is full of many triumphs and challenges, but one of the largest challenges I’ve faced over the past 41 years […]
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known […]